Company Repertoire Genesis Inc.
Equities
9217
JP3981300001
Biotechnology & Medical Research
Business Summary
Sales per Business
JPY in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
New Medical Development Support Project that Applies the Immune System
100.0
%
| 218 | 100.0 % | 417 | 100.0 % | +91.36% |
Sales per region
JPY in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 218 | 100.0 % | 417 | 100.0 % | +91.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Masuo Ichikawa
PSD | President | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ryuji Suzuki
FOU | Founder | - | - |
Masuo Ichikawa
PSD | President | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,114,000 | 0 | 0 | - |
Company contact information
Repertoire Genesis, Inc.
Saito Bio Incubator 402 7-7-15 Saito Asagi
567-0085, Osaka
+
http://www.repertoire.co.jp![address Repertoire Genesis Inc.(9217)](https://cdn.zonebourse.com/static/address/133509707.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+23.13% | 4.69TCr | |
+37.77% | 3.91TCr | |
-8.73% | 3.85TCr | |
+28.09% | 3.1TCr | |
-12.26% | 2.61TCr | |
+10.57% | 2.59TCr | |
+45.05% | 1.42TCr | |
+32.23% | 1.25TCr | |
-6.56% | 1.14TCr |